Search

Your search keyword '"Cortelezzi, A"' showing total 143 results

Search Constraints

Start Over You searched for: Author "Cortelezzi, A" Remove constraint Author: "Cortelezzi, A" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
143 results on '"Cortelezzi, A"'

Search Results

1. Combining taxonomic and functional approaches to assess land‐use impacts on macroinvertebrate assemblages and improve bioindication.

2. Lower incidence of COVID‐19 in patients with inflammatory bowel disease treated with non‐gut selective biologic therapy.

4. An Unusual Coexistence of Primary Central Nervous System Non-Hodgkin's Lymphoma and Acute Promyelocytic Leukemia.

5. Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia.

6. Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers.

7. Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases.

8. FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.

9. Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL).

10. An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

11. Biological and molecular characterization of a rare case of cutaneous Richter syndrome.

12. Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

13. Oxidative status in treatment-naïve essential thrombocythemia: a pilot study in a single center.

14. Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications.

15. Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study.

16. Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies.

17. Hereditary Xerocytosis due to Mutations in PIEZO1 Gene Associated with Heterozygous Pyruvate Kinase Deficiency and Beta-Thalassemia Trait in Two Unrelated Families.

18. Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL).

19. Compendium of FAM46C gene mutations in plasma cell dyscrasias.

20. Detection of erythroblast antibodies in mitogen-stimulated bone marrow cultures from patients with myelodysplastic syndromes.

22. Prospective validation of predictive value of abdominal computed tomography scan on time tofirst treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.

23. Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis.

24. Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.

26. Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report.

27. Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study.

29. Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

32. Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms An European Leukemia Net study.

34. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.

35. Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.

36. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia.

37. Cerebral Arterial Thrombosis in Ulcerative Colitis.

38. An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients.

39. Lenalidomide in the Treatment of Chronic Lymphocytic Leukemia.

40. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience.

42. Modulation of Maternal LIF Producers T Cells by Trophoblast and Paternal Antigens.

43. Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion.

44. The clinical and biological features of a series of immunophenotypic variant of B-CLL.

46. Bone marrow endothelial progenitors are defective in systemic sclerosis.

47. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.

48. research paper Outcomes of an automated procedure for the selection of effective platelets for patients refractory to random donors based on cross-matching locally available platelet products.

49. Theory of pH-stat titration.

Catalog

Books, media, physical & digital resources